Lung cancer classification

Revision as of 15:47, 9 June 2014 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Lung cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lung cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lung cancer classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lung cancer classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lung cancer classification

CDC on Lung cancer classification

Lung cancer classification in the news

Blogs on Lung cancer classification

Directions to Hospitals Treating Lung cancer

Risk calculators and risk factors for Lung cancer classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Kim-Son H. Nguyen, M.D., M.P.A., Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA, Cafer Zorkun, M.D., Ph.D. [2]

Overview

The vast majority of lung cancers are carcinomas—malignancies that arise from epithelial cells. There are two main types of lung carcinoma, categorized by the size and appearance of the malignant cells seen by a histopathologist under a microscope: non-small cell (80.4%) and small-cell (16.8%) lung carcinoma.[1] This classification, based on simple histological criteria, has important implications for clinical management and prognosis of the disease.

Classification

  • Primary lung cancer can be classified into two main categories: small cell lung cancer (SCLC)(~15%) and non small cell lung cancer (NSCLC) (~85%).
  • There are three main sub-types of NSCLC, which are grouped together because their prognosis and management are similar.:
  • A subtype of adenocarcinoma, the bronchioloalveolar carcinoma, is more common in female never-smokers, and may have different responses to treatment.[2]

WHO Histological Classification of Tumors of the Lung [3]

Malignant Epithelial Tumors

  • Squamous cell carcinoma
  • Papillary
  • Clear cell
  • Small cell
  • Basaloid
  • Small cell carcinoma
  • Combined small cell carcinoma
  • Adenocarcinoma
  • Adenocarcinoma, mixed subtype
  • Acinar adenocarcinoma
  • Papillary adenocarcinoma
  • Bronchioloalveolar carcinoma
  • Nonmucinous
  • Mucinous
  • Mixed nonmucinous and mucinous or indeterminate
  • Solid adenocarcinoma with mucin production
  • Fetal adenocarcinoma
  • Mucinous (“colloid”) carcinoma
  • Mucinous cystadenocarcinoma
  • Signet ring adenocarcinoma
  • Clear cell adenocarcinoma
  • Large cell carcinoma
  • Large cell neuroendocrine carcinoma
  • Combined large cell neuroendocrine carcinoma
  • Basaloid carcinoma
  • Lymphoepithelioma-like carcinoma
  • Clear cell carcinoma
  • Large cell carcinoma with rhabdoid phenotype
  • Adenosquamous carcinoma
  • Sarcomatoid carcinoma
  • Pleomorphic carcinoma
  • Spindle cell carcinoma
  • Giant cell carcinoma
  • Carcinosarcoma
  • Pulmonary blastoma
  • Carcinoid tumor
  • Typical carcinoid
  • Atypical carcinoid
  • Salivary gland tumors
  • Mucoepidermoid carcinoma
  • Adenoid cystic carcinoma
  • Epithelial-myoepithelial carcinoma
  • Preinvasive lesions
  • Squamous carcinoma in situ
  • Atypical adenomatous hyperplasia
  • Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Mesenchymal tumors
  • Epithelioid haemangioendothelioma
  • Angiosarcoma
  • Pleuropulmonary blastoma
  • Chondroma
  • Congenial peribronchial myofibroblastic tumor
  • Diffuse pulmonary lymphangiomatosis
  • Inflammatory myofibroblastic tumor
  • Lymphangioleiomyomatosis
  • Synovial sarcoma
  • Monophasic
  • Biphasic
  • Pulmonary artery sarcoma
  • Pulmonary vein sarcoma

Benign Epithelial Tumors

  • Papillomas
  • Squamous cell papilloma
  • Exophytic
  • Inverted
  • Glandular papilloma
  • Mixed squamous cell and glandular papilloma
  • Adenomas
  • Alveolar adenoma
  • Papillary adenoma
  • Adenomas of the salivary gland type
  • Mucous gland adenoma
  • Pleomorphic adenoma
  • Others
  • Mucinous cystadenoma

Lymphoproliferative Tumors

  • Marginal zone B-cell lymphoma of the MALT type
  • Diffuse large B-cell lymphoma
  • Lymphomatoid granulomatosis
  • Langerhans cell histiocytosis

Miscellaneous Tumors

  • Harmatoma
  • Sclerosing hemangioma
  • Clear cell tumor
  • Germ cell tumors
  • Teratoma, mature
  • Immature
  • Other germ cell tumors
  • Intrapulmonary thymoma
  • Melanoma

Metastatic Tumors

  • The lung is a common organ for metastasis from tumors in other parts of the body. These cancers are identified by the site of origin, thus a breast cancer metastasis to the lung is still known as breast cancer. They often have a characteristic round appearance on chest x-ray.[4]

References

  1. Travis, WD (Jan 1995). "Lung cancer". Cancer. 75 (Suppl. 1): 191–202. PMID 8000996. Unknown parameter |coauthors= ignored (help)
  2. Raz, DJ (Mar 2006). "Bronchioloalveolar carcinoma: a review". Clinical Lung Cancer. Cancer Information Group. 7 (5): 313–322. PMID 16640802. Unknown parameter |coauthors= ignored (help)
  3. Travis, William (2004). Pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon: IARC Press. ISBN 9283224183.
  4. Seo, JB (2001). "Atypical pulmonary metastases: spectrum of radiologic findings". Radiographics. 21 (2): 403–417. PMID 11259704. Retrieved 2007-09-10. Unknown parameter |coauthors= ignored (help)

Template:Tumors


Template:WikiDoc Sources